Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 1750 | $25.74 - $25.74 | $45,045 |
| 2024-04-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 1750 | $6.49 - $8.04 | $13,294 |
| 2024-04-01 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 8153 | $31.78 - $31.78 | $259,102 |
| 2024-04-01 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 8153 | $6.49 - $20.24 | $102,222 |
| 2024-03-27 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 5833 | $35.04 - $35.04 | $204,410 |
| 2024-03-27 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 5833 | $25.98 - $25.98 | $151,541 |
| 2024-03-18 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 1750 | $31.27 - $31.27 | $54,722 |
| 2024-03-18 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 1750 | $6.49 - $8.04 | $13,294 |
| 2024-02-27 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 1909 | $30.00 - $30.00 | $57,270 |
| 2024-02-27 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 1909 | $20.24 - $20.24 | $38,638 |
| 2024-02-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 1750 | $27.67 - $27.67 | $48,422 |
| 2024-02-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 1750 | $6.49 - $8.04 | $13,294 |
| 2024-02-08 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 6244 | $27.50 - $27.50 | $171,710 |
| 2024-02-08 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 6244 | $6.49 - $15.78 | $63,584 |
| 2024-02-08 | 4D Molecular Therapeutics, Inc. | Kirn David
(Chief Executive Officer) |
S | Common Stock | D | 92001 | $27.13 - $27.13 | $2,495,821 |
| 2024-02-05 | 4D Molecular Therapeutics, Inc. | Kim Robert Young
(Chief Medical Officer) |
S | Common Stock | D | 24552 | $30.05 - $30.05 | $737,787 |
| 2024-02-05 | 4D Molecular Therapeutics, Inc. | Kim Robert Young
(Chief Medical Officer) |
M | Common Stock | A | 24000 | $8.04 - $18.66 | $366,839 |
| 2024-01-23 | 4D Molecular Therapeutics, Inc. | Kirn David
(Chief Executive Officer) |
S | Common Stock | D | 5696 | $18.41 - $18.41 | $104,851 |
| 2023-12-15 | 4D Molecular Therapeutics, Inc. | Kirn David
(Chief Executive Officer) |
S | Common Stock | D | 102303 | $17.27 - $20.31 | $1,959,351 |
| 2024-01-04 | 4D Molecular Therapeutics, Inc. | Shabet Rose Sharon
(AtLeastTenPercentOwner) |
S | Common Stock | D | 540000 | $19.53 - $19.53 | $10,546,200 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |